David Cohen, Ph.D., holds degrees from McGill University, Carleton
University, and the University of California at Berkeley. He is a Professor at the School
of Social Work at Florida International University, in Miami, Florida. Dr.Cohen has previously taught at University of Montreal
and was Coordinator of the Ph.D. Program in Social Welfare at FIU. His work focuses on
describing and understanding the social, cultural, and clinical uses of
psychiatric/psychotropic drugs. He has contributed to clinical practice by elaborating
self-help and professional help methods for clients undergoing withdrawal from psychiatric
drugs.
Dr. Cohen is recognized as an expert on the adverse effects of
psychotropic drugs and on psychiatric drug withdrawal. He has authored over 100 articles
in journals of psychology, sociology, social work, medicine, health policy, and law. His research experience spans
large-scale surveys and meta-analyses to in-depth qualitative inquiries, with more than 20
externally-funded projects as principal or co-principal investigator. Dr. Cohen has edited
or co-authored eight books, including Challenging
the Therapeutic State (1990), Tardive
Dyskinesia and Cognitive Dysfunction (1993), and Your
Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Medications (with
Peter R. Breggin, M.D.). His French-language books include Medicalization and Social Control (1994), and Critical
Handbook of Psychiatric Drugs (1995). In
2003, Dr. Cohen received the Elliot Freidson Award for outstanding publication in medical
sociology from the American Sociological Association. Dr. Cohen has lectured widely
throughout the world.
Currently, Dr. Cohen is Associate
Editor of both The
Journal of Mind and Behavior and Ethical Human
Sciences and Services: An International Journal of Critical Inquiry. He serves on the editorial boards of The Review of Existential Psychology and Psychiatry
as well as The Journal of Critical Psychology,
Counselling, and Psychotherapy, and he is Consulting Editor for Social Work.
Dr. Cohen consults regularly on psychiatric drug issues with individuals,
families, and organizations. He has presented to numerous academic, professional, and
other groups, and has consulted with foreign governments on regulation of psychotropic
drugs to children.
Home